sever
acut
respiratori
syndromerel
coronaviru
result
pandem
continu
spread
around
globe
unpreced
rate
date
effect
therapeut
avail
fight
associ
diseas
discoveri
novel
insert
glycosaminoglycan
gag
bind
motif
proteolyt
cleavag
site
prrar
two
gagbindinglik
motif
within
spike
glycoprotein
sgp
led
us
hypothes
host
cell
surfac
gag
might
involv
host
cell
entri
use
surfac
plasmon
reson
direct
bind
assay
found
monomer
trimer
spike
tightli
bind
immobil
heparin
kd
pm
pm
respect
sarscov
merscov
sgp
nm
nm
respect
competit
bind
studi
heparin
trisulf
nonanticoagul
heparan
sulfat
nonanticoagul
low
molecular
weight
heparin
sgp
bind
immobil
heparin
respect
final
unbias
comput
ligand
dock
indic
heparan
sulfat
interact
gagbind
motif
site
monom
interfac
trimer
sgp
anoth
site
yrlfrk
receptorbind
domain
open
conform
studi
augment
knowledg
pathogenesi
advanc
carbohydratebas
therapeut
develop
authorfund
right
reserv
reus
allow
without
permiss
moor
mj
luo
et
al
receptor
viral
determin
sarscoronaviru
adapt
human
embo
j
authorfund
right
reserv
reus
allow
without
permiss
march
world
health
organ
declar
sever
acut
respiratori
syndromerel
coronaviru
pandem
less
three
month
initi
emerg
wuhan
china
zoonot
betacoronaviru
transmit
personperson
contact
airborn
fecalor
rout
caus
confirm
coronaviru
diseas
case
associ
death
worldwid
limit
understand
pathogenesi
extens
studi
perform
close
relat
cousin
sarscov
merscov
middl
east
respiratori
syndromerel
coronaviru
invad
host
cell
upon
initi
contact
surfac
host
cell
sarscov
merscov
exploit
host
cell
proteas
prime
surfac
spike
glycoprotein
sgp
fusion
activ
achiev
receptor
bind
low
ph
receptor
bind
domain
rbd
resid
within
subunit
subunit
facilit
viralhost
cell
membran
fusion
activ
sgp
undergo
conform
chang
follow
initi
fusion
reaction
host
cell
membran
endocytos
virion
process
endosom
proteas
cathepsin
l
late
endosom
merscov
sarscov
requir
proteolyt
cleavag
site
junction
success
membran
fusion
host
cell
entri
addit
receptor
involv
fusion
activ
sarscov
merscov
includ
heparan
sulfat
hs
angiotensinconvert
enzym
dipeptidyl
peptidas
respect
sarscov
pathogen
arriv
host
cell
surfac
cling
surfac
protein
linear
sulfat
polysaccharid
call
glycosaminoglycan
gag
repeat
disaccharid
unit
gag
compris
hexosamin
uron
acid
galactos
residu
often
sulfat
fig
gag
gener
found
coval
link
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
core
protein
proteoglycan
pg
resid
insid
cell
cell
surfac
extracellular
matrix
ecm
gag
facilit
variou
biolog
process
includ
cellular
signal
pathogenesi
immun
possess
divers
therapeut
applic
exampl
fda
approv
anticoagul
heparin
hp
secretori
gag
releas
granul
mast
cell
infect
gag
bind
protein
identifi
amino
acid
sequenc
known
cardinweintraub
motif
correspond
xbbxbx
xbbbxxbx
x
hydropath
residu
b
basic
residu
arginin
lysin
respons
interact
sulfat
group
present
gag
examin
sgp
sequenc
reveal
gagbind
motif
resid
within
proteolyt
cleavag
motif
furin
cleavag
motif
bbxbb
present
sarscov
merscov
sgp
fig
fig
fig
addit
discov
gagbindinglik
motif
within
rbd
proteolyt
cleavag
site
sgp
fig
fig
fig
discoveri
prompt
us
hypothes
gag
may
contribut
fusion
activ
host
cell
entri
novel
mechan
sgp
bind
perform
surfac
plasmon
reson
spr
base
bind
assay
determin
bind
kinet
interact
variou
gag
sgp
comparison
sarscov
merscov
sgp
address
question
lastli
perform
blind
dock
trimer
sgp
model
object
identifi
prefer
bind
gagbind
site
sgp
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
previou
report
show
variou
cov
bind
gag
sgp
invad
host
cell
current
studi
util
spr
measur
bind
kinet
interact
affin
monomer
trimer
monomer
sarscov
merscov
sgphp
use
sensor
chip
immobil
hp
sensorgram
cov
sgphp
interact
shown
fig
sensorgram
fit
global
obtain
associ
rate
constant
ka
dissoci
rate
constant
kd
equilibrium
dissoci
constant
kd
tabl
use
biaevalu
softwar
assum
langmuir
model
mer
cov
sgp
exhibit
markedli
low
dissoci
rate
constant
kd
suggest
excel
bind
strength
hp
bind
properti
monomer
sgp
compar
trimer
form
kd
monom
trimer
pm
pm
respect
comparison
previous
known
hp
bind
sarscov
sgp
show
nearli
lower
affin
nm
extrem
high
bind
affin
sgp
hp
support
chip
surfac
regener
condit
immobil
hp
surfac
could
regener
use
harsh
regener
reagent
sd
instead
standard
nacl
solut
use
remov
hpbind
protein
one
reason
sgp
monom
trimer
extrem
high
affin
immobil
heparin
high
densiti
surfac
bound
ligand
might
promot
polyval
interact
differ
bind
kinet
affin
cov
sgp
hp
may
also
due
part
differ
protein
sequenc
cov
sgp
base
amino
acid
align
analysi
use
basic
local
align
search
tool
blast
sarscov
sgp
share
similar
associ
rate
constant
ka
merscov
sgp
lowest
follow
monomer
trimer
sgp
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
respect
tabl
sarscov
sgp
highest
ka
differ
ka
valu
suggest
differ
mechan
sgp
bind
hp
addit
differ
bind
strength
solutionsurfac
competit
experi
perform
spr
examin
effect
saccharid
chain
length
hp
sgphp
interact
hpderiv
oligosaccharid
differ
length
tetrasaccharid
octadecasaccharid
use
competit
studi
concentr
nm
hp
oligosaccharid
mix
sgp
protein
nm
hp
interact
solut
neglig
competit
observ
fig
nm
oligosaccharid
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
present
protein
solut
suggest
sgphp
interact
chainlength
depend
prefer
bind
full
chain
hp
competit
level
measur
spr
chemic
modifi
hp
deriv
shown
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
concentr
depend
fashion
valu
concentr
compet
analyt
result
decreas
ru
calcul
plot
sgp
bind
signal
normal
vs
glycan
concentr
solut
fig
valu
hp
tri
hs
nach
respect
use
modifi
version
autodock
vina
tune
use
carbohydr
vinacarb
perform
blind
dock
trimer
sgp
model
discov
object
prefer
bind
gagbind
site
sgp
protein
surfac
sgp
contain
three
put
gagbind
motif
follow
sequenc
yrlfrk
prrar
skpskr
defin
site
respect
fig
fig
fig
hs
hexasaccharid
fragment
glca
glcn
bind
site
monom
chain
trimer
sgp
fig
fig
dock
result
also
indic
hs
may
bind
site
apex
monom
open
conform
allow
basic
residu
access
ligand
bind
site
residu
less
access
gag
bind
domain
close
conform
fig
electrostat
potenti
surfac
represent
trimer
sgp
confirm
gagbind
pose
gener
prefer
region
posit
charg
expect
illustr
basic
residu
within
site
expos
bind
hs
chain
fig
final
blind
dock
analysi
reveal
longer
hs
polym
may
span
interdomain
channel
contain
site
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
origin
sarscov
numer
pathogen
exploit
host
cell
surfac
gag
initi
step
host
cell
entri
base
discoveri
gagbind
gagbindinglik
motif
site
within
rbd
site
proteolyt
cleavag
site
junction
site
proteolyt
cleavag
site
hypothes
may
also
interact
host
cell
surfac
gag
sgp
invad
host
cell
fig
fig
fig
predomin
gag
normal
human
lung
hs
follow
cs
noteworthi
lung
tissu
rich
mast
cell
sourc
commerci
hp
use
unbias
dock
found
tri
hs
hexasaccharid
dock
result
indic
hs
hexasaccharid
could
span
interdomain
channel
includ
site
suggest
mechan
bind
longer
hs
sequenc
fig
next
experiment
determin
bind
kinet
interact
hp
rich
tri
domain
monomer
trimer
monomer
sarscov
monomer
merscov
sgp
use
spr
bind
assay
fig
tabl
gagprotein
interact
mainli
electrostat
driven
thu
hsbind
protein
gener
bind
hp
due
higher
degre
sulfat
discov
hp
bind
monomer
trimer
sgp
remark
affin
kd
pm
pm
respect
fig
tabl
unexpectedli
tight
bind
gagprotein
interact
even
one
one
prototyp
hpbind
protein
fibroblast
growth
factor
kd
nm
comparison
sarscov
merscov
sgp
also
bind
hp
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
howev
much
weakli
bind
strength
kd
nm
nm
respect
fig
tabl
hs
facilit
sarscov
host
cell
entri
essenti
host
cell
surfac
receptor
involv
merscov
host
cell
entri
bind
kinet
sarscov
merscov
sgp
previous
report
discov
high
bind
affin
hp
sgp
next
found
degre
posit
sulfat
within
hp
import
success
bind
monomer
sgp
fig
low
gag
suggest
fda
approv
anticoagul
hp
nonanticoagul
deriv
might
therapeut
potenti
infect
competit
inhibitor
locat
propos
gagbind
site
also
interest
unlik
sarscov
merscov
sgp
sgp
novel
insert
amino
acid
sequenc
prrar
fulli
follow
gagbind
cardinweintraub
motif
xbbxbx
furincleavag
motif
bbxbb
junction
fig
site
also
shown
prefer
gagbind
motif
unbias
dock
studi
fig
proteolyt
cleavag
requir
success
viralhost
cellular
membran
fusion
sarscov
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
merscov
sgp
proteolyt
cleavag
prime
sgp
fusion
activ
may
addit
influenc
cellcel
fusion
host
cell
entri
andor
infect
viru
possess
gagbind
furin
cleavag
motif
junction
sgp
case
mhv
ibv
spike
protein
singl
amino
acid
mutat
near
gagbind
furin
cleavag
motif
result
cell
cultur
adapt
determin
whether
virion
bind
gag
exploit
host
cell
surfac
proteas
within
cov
famili
human
immunodefici
viru
type
requir
hsbind
achiev
optim
furin
process
hs
bind
allow
select
exposur
furin
cleavag
site
idea
repurpos
hp
therapeut
sound
appeal
question
includ
vitro
relev
gag
host
cell
surfac
receptor
proteolyt
process
sgp
junction
relationship
host
cell
entri
infect
must
first
care
evalu
base
find
propos
model
gag
may
facilit
host
cell
entri
fig
first
virion
land
epitheli
surfac
airway
bind
hs
sgp
fig
host
cell
surfac
proteoglycan
util
long
hs
chain
secur
wrap
around
trimer
sgp
fig
step
heavili
sulfat
hs
chain
span
interdomain
channel
contain
gagbind
site
monom
trimer
sgp
bind
site
within
rbd
open
conform
fig
host
cell
surfac
extracellular
proteas
furin
transmembran
serin
proteas
may
process
site
junction
andor
gag
chain
come
site
upon
cleavag
fig
hs
bind
readili
access
rbd
contain
site
may
drive
conform
chang
sgp
activ
viralcellular
membran
fusion
final
sgp
endocytos
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
virion
may
util
endosom
host
cell
proteas
cathepsin
l
execut
viralcellular
membran
fusion
fig
conclus
discov
gag
facilit
host
cell
entri
bind
sgp
current
work
spr
studi
demonstr
monomer
trimer
sgp
bind
hp
remark
high
affin
prefer
long
heavili
sulfat
tri
rich
structur
addit
report
low
hp
deriv
hp
sgp
interact
suggest
therapeut
potenti
hp
competit
inhibitor
lastli
unbias
comput
ligand
dock
indic
tri
hs
oligosaccharid
prefer
interact
gagbind
motif
junction
within
receptor
bind
domain
hint
mechan
bind
studi
add
current
understand
pathogenesi
serv
foundat
design
glycoconjug
vaccin
therapeut
success
contain
elimin
hp
deriv
hp
mw
kda
gener
provid
prof
lianchun
wang
univers
south
florida
nonanticoagul
low
molecular
weight
hp
nach
synthes
dalteparin
nitrou
acid
depolymer
product
porcin
intestin
hp
follow
period
oxid
describ
previou
work
tri
hs
synthes
nsulfo
heparosan
subsequ
modif
hp
oligosaccharid
includ
tetrasaccharid
hexasaccharid
octasaccharid
decasaccharid
dodecasaccharid
tetradecasaccharid
hexadecasaccharid
octadecasaccharid
prepar
porcin
intestin
hp
control
partial
heparin
lyas
treatment
follow
size
fraction
chemic
structur
gag
shown
fig
sensor
sa
chip
ge
healthcar
uppsala
sweden
spr
measur
perform
biacor
oper
use
biacor
control
biaevalu
softwar
version
biotinyl
hp
prepar
conjug
reduc
end
pierc
rockford
il
brief
hp
mg
mg
pierc
rockford
il
dissolv
mg
ad
reaction
mixtur
heat
h
mg
ad
reaction
heat
anoth
h
cool
room
temperatur
mixtur
desalt
spin
column
mwco
biotinyl
hp
collect
freezedri
use
sa
chip
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
prepar
biotinyl
hp
immobil
streptavidin
sa
chip
base
manufactur
protocol
success
immobil
hp
confirm
observ
unit
ru
increas
sensor
chip
control
flow
cell
prepar
min
inject
satur
biotin
sgp
nm
mix
hp
hpderiv
oligosaccharid
chemic
modifi
hp
gag
spr
buffer
inject
hp
chip
flow
rate
respect
run
dissoci
regener
perform
describ
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
solut
competit
studi
surfac
hp
solubl
glycan
hp
tri
hs
nach
measur
perform
use
spr
brief
sprotein
nm
sampl
alon
mix
differ
concentr
glycan
spr
buffer
inject
hp
chip
flow
rate
respect
run
dissoci
regener
perform
describ
set
competit
experi
control
experi
protein
without
glycan
perform
ensur
surfac
complet
regener
coordin
sgp
trimer
ncbi
refer
sequenc
download
swissmodel
homolog
model
server
select
model
gener
cryoem
structur
pdb
id
templat
sequenc
ident
coverag
amino
acid
templat
result
model
prefus
structur
one
three
receptor
bind
domain
chain
open
conform
cryoem
studi
reveal
sgp
trimer
exist
two
conform
state
approxim
equal
abund
one
state
sgp
monom
domain
close
one
monom
domain
open
posit
away
interior
protein
initi
coordin
hexasaccharid
fragment
hs
glca
glcn
gener
use
gagbuild
tool
glycamweb
glycamorg
use
unbias
blind
dock
hexasaccharid
chosen
suffici
long
repres
typic
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gag
length
found
protein
cocomplex
avoid
introduc
mani
degre
intern
flexibl
effici
dock
conform
search
algorithm
impair
dock
perform
use
version
vinacarb
modifi
improv
perform
gag
grid
box
dimens
x
z
place
geometr
center
protein
enclos
entir
surfac
dock
perform
default
valu
follow
except
exhaust
chicutoff
chicoeff
sulfat
hydroxyl
group
glycosid
torsion
angl
treat
flexibl
result
ligand
pose
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
